Bloody Minded Episode 43 - When your number’s not up | Platelet Refractoriness
Apr 22, 2025
Dive into the complexities of platelet refractoriness and its impact on transfusion medicine. Explore the immune mechanisms that trigger poor responses despite transfusions, and learn about the crucial role of HLA matching in improving outcomes. The discussion covers the importance of understanding platelet increments and the various factors leading to refractoriness, including infections and medications. Discover innovative management strategies to enhance donor availability and minimize complications, making transfusions safer and more effective.
AI Snips
Chapters
Transcript
Episode notes
HLA Antigens Drive Refractoriness
- Platelets express predominantly HLA class 1 antigens, mainly HLA-A and HLA-B, which are highly polymorphic.
- Antibodies against these can cause immune-mediated platelet refractoriness.
HPA Antigens: Less Common Target
- Human platelet antigens (HPA) are platelet-specific polymorphic glycoproteins.
- HPA antibodies cause fewer refractoriness cases compared to HLA antibodies but remain clinically relevant.
Testing for HLA in Refractoriness
- Perform both HLA antigen genotyping and HLA antibody testing to diagnose causes of platelet refractoriness.
- Use PCR-based genotyping and sensitive antibody assays for accurate detection.